Since this TCR clone, shared by LTS, could reflect a pre-existing T cell-mediated immune response against GBM cells (24), we speculated that the loss or downregulation of the pre-existing antitumor immune response within tumors could contribute to the inverse correlation of high MxA expression with poorer outcomes. The gene discussed is MX1; the disease is glioblastoma.